1. At 3 Years, SES Maintain Lead Over BMS for Stemi

    The superior clinical benefit of sirolimus-eluting stents (SES) over bare-metal stents (BMS) observed in ST-segment elevation myocardial infarction (STEMI) patients 1 year after treatment is sustained out to 3 years, according to a paper in the February 23, 2010, issue of the Journal of the American College of Cardiology. Of note, the cumulative incidence of death and recurrent MI was equivalent in the SES and BMS groups after clopidogrel withdrawal. Three-year findings from the SESAMI (Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction) trial were previously presented September 22, 2009, as an oral abstract at the annual Transcatheter Cardiovascular ...
    Read Full Article

    Login to comment.

  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Topics Mentioned